I disagree with everything said here from both camps. I wasn't expecting more than what we got. we had the excellent sales as guided, the ease of use device is doing a great job of increasing sales. Clearly making a difference.
Just started and not obsolete yet.
Much better growth than jun'22 -dec22.
If great exceptional progress is mentioned between now and year end , i believe it's only meeting the high end sales target.
If the Go' delay caught you out by surprise then the loan deal caught you out too, and your gumpy and blame management. But it's the nature of the business. Be expecting more.
Me=happy with progress=happy with funding=sales growth happy= old ceo good=new ceo good.
Ann: AVITA Medical Q3 Revenue & Secures $90M Non-Dilutive Debt, page-28
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.03 |
Change
-0.050(1.62%) |
Mkt cap ! $213.3M | |||
| Open | High | Low | Value | Volume |
| $3.08 | $3.08 | $3.00 | $295.3K | 97.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1819 | $3.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.05 | 71 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |